Advances in Hepatitis Management

Description

This session will highlight recent data on therapy for chronic hepatitis D, including real-world effectiveness, safety, and predictors of treatment response. Presentations will explore outcomes across various patient populations.
 

Journey Maps

Objectives

  • Assess real-world effectiveness of hepatitis delta virus (HDV) therapies.
  • Compare treatment outcomes for hepatitis delta in various patient populations
  • Identify characteristics associated with virologic response in HDV